$Inotuzumab ozogamicin compassionate use for French paediatric patients with relapsed or refractory CD22‐positive B‐cell acute lymphoblastic leukaemia$

Inotuzumab ozogamicin compassionate use for French paediatric patients with relapsed or refractory CD22‐positive B‐cell acute lymphoblastic leukaemia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of haematology 2020-07, Vol.190 (1), p.e53-e56
Hauptverfasser:	Calvo, Charlotte, Cabannes‐Hamy, Aurélie, Adjaoud, Dalila, Bruno, Bénédicte, Blanc, Laurence, Boissel, Nicolas, Tabone, Marie‐Dominique, Willson‐Plat, Geneviève, Villemonteix, Juliette, Baruchel, André, Brethon, Benoit
Format:	Artikel
Sprache:	eng
Schlagworte:	acute lymphoblastic leukaemia Acute lymphoblastic leukemia Adolescent Antineoplastic Agents, Immunological - pharmacology Antineoplastic Agents, Immunological - therapeutic use CD22 antigen Child Child, Preschool childhood leukaemia France Hematology Humans Immunotherapy Inotuzumab Ozogamicin - pharmacology Inotuzumab Ozogamicin - therapeutic use Leukemia Monoclonal antibodies Neoplasm Recurrence, Local Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality Retrospective Studies Sialic Acid Binding Ig-like Lectin 2 - metabolism Survival Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	0007-1048 1365-2141
DOI:	10.1111/bjh.16732